NORPLANT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norplant, and when can generic versions of Norplant launch?
Norplant is a drug marketed by Population Council and Wyeth Pharms Inc and is included in two NDAs.
The generic ingredient in NORPLANT is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norplant
A generic version of NORPLANT was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORPLANT?
- What are the global sales for NORPLANT?
- What is Average Wholesale Price for NORPLANT?
Summary for NORPLANT
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Clinical Trials: | 7 |
Patent Applications: | 3,658 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NORPLANT at DailyMed |
![NORPLANT drug patent expirations Drug patent expirations by year for NORPLANT](/p/graph/s/t/NORPLANT-patent-expirations.png)
Recent Clinical Trials for NORPLANT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Women and Infants Hospital of Rhode Island | N/A |
Society of Family Planning | Phase 4 |
Oregon Health and Science University | Phase 4 |
US Patents and Regulatory Information for NORPLANT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Population Council | NORPLANT | levonorgestrel | IMPLANT;IMPLANTATION | 019897-001 | Dec 10, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Wyeth Pharms Inc | NORPLANT SYSTEM IN PLASTIC CONTAINER | levonorgestrel | IMPLANT;IMPLANTATION | 020088-001 | Dec 10, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NORPLANT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Population Council | NORPLANT | levonorgestrel | IMPLANT;IMPLANTATION | 019897-001 | Dec 10, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Population Council | NORPLANT | levonorgestrel | IMPLANT;IMPLANTATION | 019897-001 | Dec 10, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NORPLANT
See the table below for patents covering NORPLANT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 1680 | ⤷ Sign Up | |
Italy | 1061739 | PROCESSO PER PREPARARE SOSTANZE STEROIDI | ⤷ Sign Up |
Netherlands | 146502 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for NORPLANT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1453521 | 39/2015 | Austria | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
1453521 | CA 2016 00016 | Denmark | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211 |
1453521 | 93156 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |